What Happened?
Philadelphia, PA-based Context-Therapeutics Appointed Jennifer Minai-Azary as Chief Financial Officer
About the Company
Context Therapeutics Inc. (Nasdaq: CNTX) is a women`s oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers. The Company`s robust clinical program for lead candidate onapristone extended release (ONA-XR) comprises three Phase 2 clinical trials and one Phase 1b/2 clinical trial in hormone-driven breast, ovarian and endometrial cancer, as well as two Phase 0 biomarker pharmacodynamic trials in breast cancer. ONA-XR is a novel small molecule under development as a complete antagonist of the progesterone receptor, a key unchecked mechanism in hormone-driven women`s cancers.
About the Person
Jennifer Minai-Azary is Chief Financial Officer at Context Therapeutics. Previously, Jennifer held various senior HR leadership roles in the industry.
Info Source
News
Short Profile